BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
Metabolism of xenobiotics
,
Leukemia
,
Intestine
,
Pharmacogenetics
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bladder carcinomas
Summary
General Info
Curated Studies
Most Correlated Studies
Urothelial bladder carcinoma cells with KDM6A mutation and treatment with EZH2 inhibitor GSK343
Bladder carcinoma HT1197 cells after eIF3a knockdown
Bladder carcinoma HT 1197 cells treated with panobinostat
Bladder carcinoma 5637 cells with MAT1A overexpression
Bladder carcinoma JMSU-1 and 575A cells expressing RXRA WT with pioglitazone or RXRA S427F MUT
Explore Curated Studies Results
Literature
Most Relevant Literature
Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression.
Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].
Evaluation of grade and invasiveness of bladder urothelial carcinoma using infrared imaging and mach…
TBX3 stimulates proliferation and stem cell self-renewal in bladder carcinoma.
The Value Of PD-L1 Immunohistochemical Expression In Egyptian Urinary Bladder Carcinoma Patients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma
Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergo…
Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Car…
Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ